pantoprazole has been researched along with Blood Loss, Postoperative in 5 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We aimed to prospectively compare the effects of continuous infusion and intermittent dosing with pantoprazole on preventing gastric ESD-related bleeding." | 2.90 | Continuous Infusion versus Intermittent Dosing with Pantoprazole for Gastric Endoscopic Submucosal Dissection. ( Baek, DH; Jeon, HK; Kim, DU; Kim, GH; Lee, BE; Seo, JH; Song, GA, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sgourakis, G | 1 |
| Chatzidakis, G | 1 |
| Poulou, A | 1 |
| Malliou, P | 1 |
| Argyropoulos, T | 1 |
| Ravanis, G | 1 |
| Vagia, A | 1 |
| Kpogho, I | 1 |
| Briki, A | 1 |
| Tsuruhara, H | 1 |
| Stankovičová, T | 1 |
| Lee, BE | 1 |
| Kim, GH | 1 |
| Song, GA | 1 |
| Seo, JH | 1 |
| Jeon, HK | 1 |
| Baek, DH | 1 |
| Kim, DU | 1 |
| Baeg, MK | 1 |
| Choi, MG | 1 |
| Moon, SJ | 1 |
| Lim, CH | 1 |
| Kim, JS | 1 |
| Cho, YK | 1 |
| Park, JM | 1 |
| Lee, IS | 1 |
| Kim, SW | 1 |
| Choi, KY | 1 |
| Jung, YS | 1 |
| Kim, KO | 1 |
| Lee, SH | 1 |
| Jang, BI | 1 |
| Kim, TN | 1 |
| Jeong, HK | 1 |
| Park, CH | 1 |
| Jun, CH | 1 |
| Lee, GH | 1 |
| Kim, HI | 1 |
| Kim, HS | 1 |
| Choi, SK | 1 |
| Rew, JS | 1 |
1 review available for pantoprazole and Blood Loss, Postoperative
| Article | Year |
|---|---|
High-dose vs. Low-dose Proton Pump Inhibitors post-endoscopic hemostasis in patients with bleeding peptic ulcer. A meta-analysis and meta-regression analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Dose-Response Relationship, Drug; Female; Hemostasis, | 2018 |
4 trials available for pantoprazole and Blood Loss, Postoperative
| Article | Year |
|---|---|
Continuous Infusion versus Intermittent Dosing with Pantoprazole for Gastric Endoscopic Submucosal Dissection.
Topics: Aged; Endoscopic Mucosal Resection; Female; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Infusi | 2019 |
Preprocedural rabeprazole treatment before endoscopic submucosal dissection for gastric neoplasms.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Dissection; Female; Gastric Mucosa; Gastrointestinal | 2014 |
[Comparison on Oral versus Intravenous Proton Pump Inhibitors for Prevention of Bleeding after Endoscopic Submucosal Dissection of Gastric Lesions].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aged; Anticoagulants; Endoscopic Muco | 2016 |
A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Dissection; Famotidine; Female; Ga | 2007 |